13 results
Keyword sotrovimab Remove keyword
Type of content
News Remove News filter
-
List item
News: ETF warns that monoclonal antibodies may not be effective against emerging strains of SARS-CoV-2
Last updated: 09/12/2022imdevimab) and Xevudy (sotrovimab). EMA has issued advice on … -
List item
News: EMA adopts first list of critical medicines for COVID-19
Last updated: 08/06/2022 -
List item
News: Emer Cooke’s end-of-year message
Last updated: 22/12/2021Article 5(3) 21 May 2021 sotrovimab opinion, Article 5(3) 16 … tocilizumab) • Xevudy (sotrovimab) • Kineret (anakinra) • … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 13-16 December 2021
CHMP, Last updated: 17/12/2021sotrovimab) received a positive opinion … -
List item
News: COVID-19: EMA recommends authorisation of antibody medicine Xevudy
CHMP, Last updated: 16/12/2021monoclonal antibody Xevudy (sotrovimab) for the treatment of COVID-19 … -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 29 November - 2 December 2021
PRAC, Last updated: 03/12/2021 -
List item
News: EMA receives application for marketing authorisation for Xevudy (sotrovimab) for treating patients with COVID-19
CHMP, PDCO, PRAC, Last updated: 18/11/2021authorisation for Xevudy (sotrovimab) for treating patients with … authorisation for Xevudy (sotrovimab) for treating patients with … -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 25-28 October 2021
PRAC, Last updated: 29/10/2021 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 30 August – 2 September 2021
PRAC, Last updated: 17/09/2021 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 5-8 July 2021
PRAC, Last updated: 09/07/2021 -
List item
News: EMA issues advice on use of sotrovimab (VIR-7831) for treating COVID-19
CHMP, Last updated: 21/05/2021EMA issues advice on use of sotrovimab (VIR-7831) for treating COVID … of the monoclonal antibody sotrovimab (also known as VIR-7831 and … The Agency concluded that sotrovimab can be used to treat confirmed … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 17-20 May 2021
CHMP, Last updated: 21/05/2021COVID-19: Advice on use of sotrovimab (VIR-7831) for treating COVID-19 … of the monoclonal antibody sotrovimab (also known as VIR-7831 … -
List item
News: EMA starts rolling review of sotrovimab (VIR-7831) for COVID-19
CHMP, Last updated: 07/05/2021EMA starts rolling review of sotrovimab (VIR-7831) for COVID-19 … ‘rolling review’ of data on sotrovimab (also known as VIR-7831 and … review. A separate review of sotrovimab is already underway to provide …